Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cancer Research

• Publication date

  2004-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-03-0643PMID 15217932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNM Atlas : Illustrated Guide to the TNM Classification of Malignant Tumours

  2005cited by this paper
• Altered methylation of multiple genes in carcinogenesis of the prostate

  2004cited by this paper
• Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.

  2003cited by this paper
• Altered methylation of multiple genes in carcinogenesis of the prostate

  2003cited by this paper
• Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.

  2003cited by this paper
• Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies.

  2003cited by this paper
• I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.

  2002cited by this paper
• Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.

  2002cited by this paper
• Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. 1974.

  2002cited by this paper
• Immunohistochemical localization of the retinoic Acid receptors in human prostate.

  2002cited by this paper
• Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.

  2002cited by this paper
• Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.

  2001cited by this paper
• Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

  2001cited by this paper
• Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.

  2001cited by this paper
• Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

  2001cited by this paper
• Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

  2000cited by this paper
• Differential expression of nuclear retinoid receptors in normal and malignant prostates.

  2000cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• ACCELERATED DISCOVERY Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

  2000cited by this paper
• Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer.

  1999cited by this paper
• Phase II study of all-trans retinoic acid administered intermittently for hormone refractory prostate cancer.

  1999cited by this paper
• Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.

  1998cited by this paper
• Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide.

  1998cited by this paper
• LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids.

  1997cited by this paper
• Prognostic factors for clinically localized prostate carcinoma

  1997cited by this paper
• Activation of the retinoic acid receptor β gene by 5-aza-2’-deoxycytidine in human DLD-1 colon carcinoma cells

  1997cited by this paper
• Retinoids in cancer chemoprevention

  1996cited by this paper
• Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration.

  1996cited by this paper
• A modified and improved method for bisulphite based cytosine methylation analysis.

  1996cited by this paper
• Prostate Biopsy Interpretation

  1995cited by this paper
• Prostatic Intraepithelial Neoplasia

  1994cited by this paper
• Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy.

  1993cited by this paper
• Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells.

  1993cited by this paper
• A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.

  1992cited by this paper
• Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

  1974cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii

  year unknowncited by this paper

• International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The Prostate.

  2025cites this paper
• DNA Methylation in Prostate Cancer: Clinical Implications and Potential Applications

  2025cites this paper
• Epigenetic (De)regulation in Prostate Cancer.

  2023cites this paper
• The Potential Role of Mitochondrial Acetaldehyde Dehydrogenase 2 in Urological Cancers From the Perspective of Ferroptosis and Cellular Senescence

  2022cites this paper
• Promoter hypermethylation of candidate tumor suppressor genes in urinary bladder and prostate cancer

  2021cites this paper
• Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma.

  2019cites this paper
• Frequent Methylation of RASSF 1 and RARB in Urine Sediments From Patients with Early Stage Prostate Cancer

  2018cites this paper
• Expression and Regulation of Retinoic Acid Receptor Responders in the Human Placenta

  2018cites this paper
• Hypermethylated WNT10A and its clinical significance in colorectal cancer.

  2018cites this paper
• Clinical Significance of Retinoic Acid Receptor Beta Promoter Methylation in Prostate Cancer: A Meta-Analysis

  2018cites this paper
• DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).

  2017influential citation
• DNA and Histone Methylation in Prostate Cancer

  2017cites this paper
• Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma

  2017cites this paper
• DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects

  2016cites this paper
• High Grade Prostatic Intraepithelial Neoplasia and Atypical Glands

  2016cites this paper
• Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile.

  2016cites this paper
• Correlation between methylation of the E-Cadherin gene and malignancy of prostate cancer.

  2016cites this paper
• Epigenetic Biomarkers in Personalized Medicine

  2015cites this paper
• DNA Methylation and Flavonoids in Genitourinary Cancers

  2015cites this paper
• Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue

  2015cites this paper
• Prostate cancer: The main risk and protective factors-Epigenetic modifications.

  2015cites this paper
• Promoter hypermethylation as a biomarker in prostate adenocarcinoma.

  2015cites this paper
• Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma

  2014cites this paper
• Meta-analyses of methylation markers for prostate cancer

  2014cites this paper
• Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia

  2014cites this paper
• Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.

  2014cites this paper
• Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.

  2014cites this paper
• Epigenetic biomarkers in urological tumors: A systematic review.

  2014cites this paper
• Retinoids: Nutritional, Cellular, and Pharmacological Roles of the Vitamin A Derivatives

  2014cites this paper
• Advanced progress on the relationship between RA and its receptors and malignant tumors.

  2014influential citation
• Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer

  2013cites this paper
• The Role of a Panel of Three Epigenetic Biomarkers in the Detection and Prognosis of Upper Urinary Tract Urothelial Carcinoma

  2013cites this paper
• Epigenetics and Racial Disparities in Prostate Cancer

  2013cites this paper
• Efficacy of Bisulfite Modification and DNA Recovery Using Commercial Kits from Samples of Genomic and Circulating DNA

  2013cites this paper
• DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer.

  2013cites this paper
• Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia

  2013cites this paper
• Subtypes of white blood cells in patients with prostate cancer or benign prostatic hyperplasia and healthy individuals.

  2013cites this paper
• Epigenetic Changes in Prostate Cancer

  2013cites this paper
• Award Number: W81XWH-11-1-0567 TITLE: GLOBAL EPIGENETIC CHANGES MAY UNDERLIE ETHNIC DIFFERENCES AND SUSCEPTIBILTY TO PROSTATE CANCER PRINCIPAL INVESTIGATOR: BERNARD KWABI-ADDO PhD CONTRACTING ORGANIZATION: HOWARD

  2013cites this paper
• The Association of Retinoic Acid Receptor Beta2(RARβ2) Methylation Status and Prostate Cancer Risk: A Systematic Review and Meta-Analysis

  2013cites this paper
• Investigating the dual roles of STRA6 in cell signaling and vitamin A trafficking

  2012cites this paper
• Epstein-Barr Virus latent membrane protein 1 overcomes all-trans retinoic acid-induced apoptosis by inhibiting retinoic acid receptor-β₂ expression.

  2012cites this paper
• Diagnostic and prognostic molecular biomarkers for prostate cancer

  2012cites this paper
• Assessment of field effect in the cancerous prostate

  2012cites this paper
• Retinoic acid receptor β2 (RARβ2): nonivasive biomarker for distinguishing malignant versus benign prostate lesions from bodily fluids.

  2012cites this paper
• The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression

  2012cites this paper
• Retinoids, retinoic acid receptors, and cancer.

  2011cites this paper
• Epigenetics in prostate cancer: biologic and clinical relevance.

  2011cites this paper
• Detection of DNA Hypermethylation as a Potential Biomarker for Prostate Cancer

  2011cites this paper
• Cytogenomic aberrations associated with prostate cancer.

  2011cites this paper
• Clinical trial update and novel therapeutic approaches for metastatic prostate cancer.

  2011cites this paper
• Molecular markers for diagnosis and prognosis in cervical neoplasia

  2011cites this paper
• High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions

  2011cites this paper
• Genetic, epigenetic and functional analysis of tumorigenesis in neurofibromatosis type 1 (NF1)

  2011cites this paper
• The androgen receptor and stem cell pathways in prostate and bladder cancers (review).

  2011cites this paper
• Aberrant DNA Methylation and Prostate Cancer

  2011cites this paper
• Epigenetics in Prostate Cancer

  2011cites this paper
• The role of the Eph and ephrin proteins in prostate cancer

  2011cites this paper
• Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.

  2011cites this paper
• Epigenetic diagnostics of cancer — the application of DNA methylation markers

  2010cites this paper
• Nuclear receptor co-repressor functions in prostate cancer; in vitro, in vivo and in silico approaches

  2010cites this paper
• Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples

  2010cites this paper
• Detection of DNA hypermethylation as a diagnostic tool in cervical neoplasma tool in cervical neoplasia

  2010cites this paper
• Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples

  2010cites this paper
• Detection of DNA hypermethylation as a diagnostic tool in cervical neoplasma tool in cervical neoplasia

  2010cites this paper
• Oxidative Stress and DNA Methylation in Prostate Cancer

  2010cites this paper
• Gene Promoter Methylation and Its Potential Relevance in Early Prostate Cancer Diagnosis

  2010cites this paper
• Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy.

  2010cites this paper
• Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers

  2010cites this paper
• Epigenetic Regulatory Mechanisms Distinguish Retinoic Acid-mediated Transcriptional Responses in Stem Cells and Fibroblasts*

  2010cites this paper
• Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours

  2010cites this paper
• Promoter methylation profile of GSTP1 and RASSF1A in benign hyperplasia and metastatic prostate cancer patients in a Kashmiri population.

  2010cites this paper
• GSTP1 Hypermethylation for Prostate Cancer Detection

  2009cites this paper
• Minireview: Epigenetic Alterations in Human Prostate Cancers

  2009cites this paper
• Epigenetic targets in cancer epidemiology.

  2009cites this paper
• Reversal of Estrogen Receptor Beta Epigenetic Gene Silencing in Prostatic Adenocarcinoma by Soy Protein-Derived Isoflavonoid Supplementation

  2009cites this paper
• Association between Lifestyle Factors and CpG Island Methylation in a Cancer-Free Population

  2009cites this paper
• DNA methylation changes in prostate cancer: current developments and future clinical implementation

  2009cites this paper
• Epigenetic alterations in human prostate cancers.

  2009cites this paper
• Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review).

  2009cites this paper
• Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells

  2009cites this paper
• Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.

  2009cites this paper
• Methylation Markers for CCNA1 and C13ORF18 Are Strongly Associated with High-Grade Cervical Intraepithelial Neoplasia and Cervical Cancer in Cervical Scrapings

  2009cites this paper
• CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.

  2008cites this paper
• Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications

  2008cites this paper
• Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR

  2008cites this paper
• Characterization of TMPRSS 2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications

  2008cites this paper
• Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions

  2008cites this paper
• Epstein-Barr virus latent membrane protein 1 suppresses the growth-inhibitory effect of retinoic acid by inhibiting retinoic acid receptor-beta2 expression via DNA methylation.

  2008cites this paper
• Quantitative, spatial resolution of the epigenetic field effect in prostate cancer

  2008cites this paper
• Epigenetic Gene Silencing in Prostate Cancer

  2008cites this paper
• RASSF1A promoter methylation is frequently detected in both pre‐malignant and non‐malignant microdissected prostatic epithelial tissues

  2007cites this paper
• Methylation-based biomarkers for early detection of urological cancer.

  2007cites this paper
• Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage

  2007cites this paper
• Somatic DNA Methylation Changes and Prostatic Carcinogenesis

  2007cites this paper
• Prostate Cancer Epigenetics: A Review on Gene Regulation

  2007cites this paper
• High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Biopsies from Prostate Cancer Patients

  2007cites this paper
• Epigenetic Markers for Molecular Detection of Prostate Cancer

  2007cites this paper
• Age-Related DNA Methylation Changes in Normal Human Prostate Tissues

  2007cites this paper
• CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer.

  2007cites this paper